Desfechos clínicos precoces e tardios após tratamento de enxertos de veia safena com stents MGuard™ vs. stents farmacológicos

The use of the MGuard™ stent resulted in a reduction of events during hospitalization; however, in the long term the DES were superior in reducing major outcomes, mainly the need for target lesion revascularization.